MVA-BN (IMVAMUNE) immunization in persons who have undergone prior hematopoietic stem cell transplant (HSCT): a phase I, placebo-controlled study of the safety, reactogenicity and immunogenicity of MVA immunization.
Phase of Trial: Phase I
Latest Information Update: 01 Aug 2013
At a glance
- Drugs Smallpox vaccine (Primary)
- Indications Smallpox
- Focus Adverse reactions
- 09 Aug 2012 Actual end date (May 2012) added as reported by ClinicalTrials.gov.
- 03 May 2012 Planned End Date changed from 1 Feb 2012 to 1 Jun 2012 as reported by ClinicalTrials.gov.
- 01 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.